Willingness to pay for a QALY: Theoretical and methodological issues

PharmacoEconomics

Volumn 23, Issue 5, 2005, Pages 423-432

  Gyrd Hansen, Dorte ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE UTILIZATION; HUMAN; INCOME; PERCEPTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; TASK PERFORMANCE; THEORETICAL STUDY; WELFARE;

COST-BENEFIT ANALYSIS; HEALTH PLANNING; HUMANS; QUALITY-ADJUSTED LIFE YEARS;

EID: 22244456103     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200523050-00002     Document Type: Review

References (37)

1. Johannesson M. The relationship between cost-effectiveness analysis and cost benefit analysis. Soc Sci Med 1995; 41: 483-9
2. Johannesson M, Meltzer D. Some reflections on cost-effectiveness analysis. Health Econ 1998; 7: 1-7
3. Laska EM, Meisner M, Siegel C, et al. Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence. Health Econ 1999; 8: 171-8
4. Hirth RA, Chernew ME, Miller E, et al. Willingness to pay for quality-adjusted life year: in search of a standard. Health Econ 2000; 20: 332-42
5. Laupacis A, Feeny D, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992; 146: 473-81
6. George B, Harris A, Mitchell A. Cost-effectiveness analysis and the consistency of decision making. Pharmacoeconomics 2001; 19 (11): 1103-9
7. Gyrd-Hansen D. Willingness to pay for a QALY. Health Econ 2003; 12: 1049-60
8. Dolan P. The measurement of health-related quality of life. In: Culyer A, Newhouse J, editors. Handbook of Health Economics. Vol. 1B. Amsterdam: Elsevier Science, 2000: 1724-62
9. Fryback DG, Lawrence WF. Dollars may not buy as many QALYs as we think: a problem of defining quality-of-life adjustments. Med Decis Making 1997; 17: 276-84
10. Bleichrodt H, Quiggin J. Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis? J Health Econ 1999; 18: 681-708
11. Dolan P, Edlin R. Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis? J Health Econ 2002; 21: 827-43
12. Pratt JW, Zeckhauser RJ. Willingness to pay and the distribution of risk and death. J Polit Econ 1996; 4: 747-63
13. Johannesson and O'Conor. Cost-utility analysis from a societal perspective. Health Policy 1997; 39: 241-53
14. Brekke KA. The numéraire matters in cost-benefit analysis. J Public Econ 1997; 64: 117-23
15. Gyrd-Hansen D, Søgaard J. Discounting life-years: whither time preference? Health Econ 1998; 7: 121-7
16. Donaldson C, Birch S, Gafni A. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes. Health Econ 2002; 11 (1): 55-70
17. Dolan P, Olsen JA, Menzel P, et al. An inquiry into the different perspectives that can be used when eliciting preferences in health. Health Econ 2003; 12: 545-51
18. Gafni A. Willingness-to-pay as a measure of benefits. Med Care 1991; 29 (12): 1246-52
19. Neumann PJ, Johannesson M. The willingness to pay for in vitro fertilization: a pilot study using contingent valuation. Med Care 1994; 32 (7): 686-99
20. Olsen JA, Smith RD. Theory versus practice: a review of 'willingness-to-pay' in health and health care. Health Econ 2002; 10: 39-52
21. Dolan P, Cookson R. A qualitative study of the extent to which health gain matters when choosing between groups of patients. Health Policy 2000; 51: 19-30
22. Cookson R, Dolan P. Public views on health care rationing: a groups discussion study. Health Policy 1999; 49: 63-74
23. Abellan-Perpinãn JM, Pinto-Prades JL. Health state after treatment: a reason for discrimination? Health Econ 1999; 8: 701-7
24. Dolan P, Green C. Using the person trade-off approach to examine differences between individual and social values. Health Econ 1998; 7: 307-12
25. Nord E. Health state index models for use in resource allocation decisions: a critical review in the light of observed preferences for social choice. Int J Technol Assess Health Care 1996; 12 (1): 31-44
26. Rodriguez E, Pinto JL. The social value of health programmes: is age a relevant factor? Health Econ 2000; 9: 611-21
27. Ryynänen OP, Myllykangan M, Kinnunen J, et al. Attitudes to health care prioritisation methods and criteria among nurses, doctors, politicians and the general public. Soc Sci Med 1999; 49: 1529-39
28. Tsuchiya A. Age-related preferences and age weighting health benefits. Soc Sci Med 1999; 48: 267-76
29. Chamy MC, Lewis PA, Farrow SC. Choosing who shall not be treated in the NHS. Soc Sci Med 1989; 28: 1331-8
30. Ratcliffe J. Public preferences for the allocation of donor liver grafts for transplantation. Health Econ 2000; 9: 137-48
31. Johannesson M, Johannesson PO. A note on the prevention versus cure. Health Policy 1997; 41: 181-7
32. Ubel PA, Loewenstein G, Scanlon D, et al. Individual utilities are inconsistent with rationing choices: a partial explanation of why Oregon's cost-effectiveness list failed. Med Decis Making 1996; 16: 108-16
33. Ubel PA. How stable are peoples' preferences for giving priority to severely ill patients? Soc Sci Med 1999; 49: 895-903
34. Nord E, Richardson J, Macarounas KK. Social evaluation of health care versus personal evaluation of health states: evidence on the validity of four health state scaling instruments using Norwegian and Australian surveys. Int J Health Technol Assess Health Care 1993; 9: 463-78
35. Nord E. The person-trade-off approach to valuing health care programs. Med Decis Making 1995; 15 (3): 201-8
36. Ubel PA, Baron J, Nash B, et al. Are preferences for equity over efficiency in health care allocation 'all or nothing'? Med Care 2000; 38: 366-73
37. Teng TO, Adams ME, Pliskin JS, et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995; 15 (3): 369-90